Pricing & Reimbursement
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| About the Pricing & Reimbursement category |
|
0 | 42 | February 12, 2024 |
| First Benefit Assessment for a diagnostic agent in Germany |
|
0 | 20 | July 16, 2024 |
| Dengvaxia discontinuation in the US |
|
0 | 20 | July 5, 2024 |
| Use of a QoL assessment tool other than EQ-5D in the NICE submission |
|
0 | 28 | June 14, 2024 |
| AMCP dossiers in the US |
|
1 | 36 | June 14, 2024 |
| UK Pricing Scheme - VPAG vs VPAS |
|
2 | 51 | May 27, 2024 |
| Appropriate Comparator for the GBA |
|
1 | 39 | May 23, 2024 |
| Price Negotiation with the CEPS in France |
|
1 | 70 | May 8, 2024 |
| Drug prices in the US |
|
6 | 72 | April 29, 2024 |
| G-BA requirements for COAs |
|
4 | 58 | April 28, 2024 |
| EU HTA Vaccines |
|
1 | 45 | April 25, 2024 |
| Treat and Reduce Obesity Act |
|
3 | 43 | April 25, 2024 |
| Inflation reduction act - prices negotiation |
|
2 | 58 | April 16, 2024 |
| EU HTA scoping phase |
|
2 | 59 | April 13, 2024 |
| Submission of documents on the SESAME platform |
|
1 | 38 | April 4, 2024 |
| Off-label use reimbursement |
|
5 | 102 | March 14, 2024 |